Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

Hozzl · 2023-12-15T15:55:42Z

Explore the details of House Bill 1629 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/15/2023, 3:55 PM

Summary of Bill HR 1629

Bill 118 hr 1629, also known as the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023, aims to regulate the production and sale of hemp and hemp-derived CBD products in the United States. The bill seeks to protect consumers by ensuring that these products meet certain quality and safety standards.

Under the provisions of the bill, hemp and hemp-derived CBD products would be subject to testing and labeling requirements to ensure that they contain the appropriate levels of CBD and do not exceed the legal limit of THC, the psychoactive compound found in marijuana. The bill also establishes a regulatory framework for the cultivation, processing, and sale of hemp and hemp-derived CBD products, including licensing requirements for producers and distributors.

Additionally, the bill includes provisions to address the issue of market stabilization by establishing a national hemp marketing program to promote the sale and consumption of hemp products. This program would be funded through fees collected from producers and distributors of hemp and hemp-derived CBD products. Overall, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 seeks to ensure that consumers have access to safe and high-quality hemp and hemp-derived CBD products, while also promoting the growth of the hemp industry in the United States.

Congressional Summary of HR 1629

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1629

Bill HR 1629 is currently in the status of Bill Introduced since March 17, 2023. Bill HR 1629 was introduced during Congress 118 and was introduced to the House on March 17, 2023. Bill HR 1629's most recent activity was Referred to the Subcommittee on Health. as of March 24, 2023

Bipartisan Support of Bill HR 1629

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1629

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 1629

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

To make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.